New targets of β-catenin signaling in the liver are involved in the glutamine metabolism

Oncogene

Volumn 21, Issue 54, 2002, Pages 8293-8301

  Cadoret, Axelle ^a   Ovejero, Christine ^a   Terris, Benoit ^b   Souil, Evelyne ^a   Lévy, Laurence ^c   Lamers, Wouter H ^d   Kitajewski, Jan ^e   Kahn, Axel ^a   Perret, Christine ^a  

^a INSTITUT COCHIN   (France)

^b Hopital Cochin Service d'Anatomopathologie ^*  (France)

^c INSTITUT PASTEUR   (France)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

^e Department of Pathology College of Physicians and Surgeons Columbia University ^*  (United States)

Author keywords

Glutamate transporter GLT 1; Glutamine synthetase; Hepatocellular carcinoma; Ornithine aminotransferase; catenin

Indexed keywords

BETA CATENIN; BETA GALACTOSIDASE; COMPLEMENTARY DNA; GLUTAMATE AMMONIA LIGASE; GLUTAMATE TRANSPORTER; GLUTAMINE; ORNITHINE OXOACID AMINOTRANSFERASE; RNA;

ADENOVIRUS; AMINO ACID METABOLISM; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ENZYME ACTIVITY; GENE OVEREXPRESSION; GENE TRANSFER; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; LIVER DISEASE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ADENOVIRIDAE; ANIMALIA; MUS MUSCULUS;

EID: 0037191930     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206118     Document Type: Article

References (26)

1. Bennoun M, Grimber G, Couton D, Seye A, Molina T, Briand P and Joulin V. (1998). Oncogene, 17, 1253-1259.
2. Bosch FX, Ribes J and Borras J. (1999). Semin. Liver Dis., 19, 271-285.
3. Buendia MA. (2000). Semin. Cancer Biol., 10, 185-200.
4. Cadoret A, Ovejero C, Saadi-Kheddouci S, Souil E, Fabre M, Romagnolo B, Kahn A and Perret C. (2001). Cancer Res., 61, 3245-3249.
5. Christa L, Simon MT, Flinois JP, Gebhardt R, Brechot C and Lasserre C. (1994). Gastroenterology, 106, 1312-1320.
6. de La Coste A, Mignon A, Fabre M, Gilbert E, Poteu A, Van Dyke T, Kahn A and Perret C. (1999). Cancer Res., 59, 5017-5022.
7. de La Coste A, Romagnolo B, Billuart P, Renard CA, Buendia MA, Soubrane O, Fabre M, Chelly J, Beldjord C, Kahn A and Perret C. (1998). Proc. Natl. Acad. Sci. USA, 95, 8847-8851.
8. Ferry N and Heard JM. (1998). Hum. Gene Ther., 9, 1975-1981.
9. Gebhardt R and Mecke D. (1983). EMBO J., 2, 567-570.
10. Gebhardt R and Williams GM. (1995). Carcinogenesis, 16, 1673-1681.
11. Harada N, Miyoshi H, Murai N, Oshima H, Tamai YU, Oshima M and Taketo MM. (2002). Cancer Res., 62, 1971-1977.
12. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B and Kinzler KW. (1998). Science, 281, 1509-1512.
13. Kallioniemi OP, Wagner U, Kononen J and Sauter G. (2001). Hum. Mol. Genet., 10, 657-662.
14. Koch A, Denkhaus D, Albrecht S, Leuschner I, von Schweinitz D and Pietsch T. (1999). Cancer Res., 59, 269-273.
15. Kovacevic Z and McGivan JD. (1983). Physiol Rev., 63, 547-605.
16. Kuo FC and Darnell Jr JE. (1991). Mol. Cell. Biol., 11, 6050-6058.
17. Laurent-Puig P, Legoix P, Bluteau O, Belghiti J, Franco D, Binot F, Monges G, Thomas G, Bioulac-Sage P and Zucman-Rossi J. (2001). Gastroenterology, 120, 1763-1773.
18. Miyasaka Y, Enomoto N, Nagayama K, Izumi N, Marumo F, Watanabe M and Sato C. (2001). Br. J. Cancer, 85, 228-234.
19. Osada T, Nagashima I, Tsuno NH, Kitayama J and Nagawa H. (2000). J. Hepatol., 33, 247-253.
20. Palos TP, Zheng S and Howard BD. (1999). J. Neurochem., 73, 1012-1023.
21. Polakis P. (2000). Genes Dev., 14, 1837-1851.
22. Satoh S, Daigo Y, Furukawa Y, Kato T, Miwa N, Nishiwaki T, Kawasoe T, Ishiguro H, Fujita M, Tokino T, Sasaki Y, Imaoka S, Murata M, Shimano T, Yamaoka Y and Nakamura Y. (2000). Nat. Genet., 24, 245-250.
23. Tetsu O and McCormick F. (1999). Nature, 398, 422-426.
24. Umeda T, Yamamoto T, Kajino K and Hino O. (2000). Int. J. Oncol., 16, 1133-1136.
25. Wei Y, Fabre M, Branchereau S, Gauthier F, Perilongo G and Buendia MA. (2000). Oncogene, 19, 498-504.
26. Young CS, Kitamura M, Hardy S and Kitajewski J. (1998). Mol. Cell. Biol., 18, 2474-2485.